← Back to Search

Primary Care Linkage for Addiction Treatment (Linkage Trial)

N/A

Waitlist Available

Led By Constance M Weisner, DrPH, LCSW

Research Sponsored by Kaiser Permanente

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Research participants will be adult patients at the Kaiser Permanente San Francisco Chemical Dependency Recovery Program, who have completed 2 weeks of treatment.

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 and 24 months post baseline

Awards & highlights

No Placebo-Only Group

Summary

This trial improves drug abuse treatment by connecting specialty drug treatment and primary health care.

Who is the study for?

This trial is for adults at the Kaiser Permanente San Francisco Chemical Dependency Recovery Program who have finished at least 2 weeks of treatment for substance use disorders, including addiction and alcoholism. Those with dementia, mental retardation, or current psychosis or suicidal tendencies cannot participate.

What is being tested?

The study tests a 'linkage patient activation intervention' designed to improve connections between specialty drug treatment and primary health care as part of enhancing overall drug abuse treatment.

What are the potential side effects?

Since this trial involves a linkage intervention rather than medication, it does not directly list side effects like drug trials do. However, participants may experience stress or anxiety related to changes in their care routine.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am an adult who has completed 2 weeks at Kaiser's San Francisco addiction recovery program.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 and 24 months post baseline

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 and 24 months post baseline

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 and 24 months post baseline for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Substance use and mental health outcomes

patient activation measure

patient engagement in health care (including patient portal use, familiarity and satisfaction with Primary Care physician, and CD treatment length of stay)

Secondary study objectives

Health care utilization and cost

Substance use and mental health outcomes at 12 and 24 months

patient activation measure at 12 and 24 months

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Linkage patient activation interventionExperimental Treatment1 Intervention

Usual Care with the exception that the six 45-min Linkage patient activation education groups replaced the six 45-min Usual Care medical education groups, plus a linkage phone call (and/or a facilitated email) with the patient, clinician, and Primary Care physician.

Group II: Usual CareActive Control1 Intervention

Usual CD treatment, including therapy groups and individual counseling sessions, and six 45-min medical education groups. Physician appointments, pharmacotherapy, and SUD medications were be available as needed.

0 / 1Eligibility criteria met